II期结肠癌患者化疗疗效与若干高危因素相关

Min Joo Kim, Seung-hyun Baek, S. Ko
{"title":"II期结肠癌患者化疗疗效与若干高危因素相关","authors":"Min Joo Kim, Seung-hyun Baek, S. Ko","doi":"10.14216/KJCO.18020","DOIUrl":null,"url":null,"abstract":"Treatment of colon cancer consists of surgical resection and chemotherapy. Stage II colon cancer is categorized into a high-risk group and low-risk group for recurrence, and chemotherapy is recommended for the high-risk group [1]. High-risk factors are perineural invasion, lymphovascular emboli, lymph node harvest less than 12, T4 stage, positive resection margin, obstruction, and perforation [2-4]. There is no doubt over treatment with chemotherapy for stage II colon cancer patients having high-risk factors. However, chemotherapy could cause side effects that makes patients’ compliance lower. Physicians face this dilemma, especially with patients who are old or have severe comorbidities. Therefore, this study was designed to determine the effectiveness of chemotherapy for patients with stage II colon cancer according to the number of high-risk factors.","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The efficacy of chemotherapy in the patients with stage II colon cancer associated with number of high-risk factors\",\"authors\":\"Min Joo Kim, Seung-hyun Baek, S. Ko\",\"doi\":\"10.14216/KJCO.18020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment of colon cancer consists of surgical resection and chemotherapy. Stage II colon cancer is categorized into a high-risk group and low-risk group for recurrence, and chemotherapy is recommended for the high-risk group [1]. High-risk factors are perineural invasion, lymphovascular emboli, lymph node harvest less than 12, T4 stage, positive resection margin, obstruction, and perforation [2-4]. There is no doubt over treatment with chemotherapy for stage II colon cancer patients having high-risk factors. However, chemotherapy could cause side effects that makes patients’ compliance lower. Physicians face this dilemma, especially with patients who are old or have severe comorbidities. Therefore, this study was designed to determine the effectiveness of chemotherapy for patients with stage II colon cancer according to the number of high-risk factors.\",\"PeriodicalId\":74045,\"journal\":{\"name\":\"Korean journal of clinical oncology\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean journal of clinical oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14216/KJCO.18020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14216/KJCO.18020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

结肠癌的治疗包括手术切除和化疗。II期结肠癌复发分为高危组和低危组,高危组推荐化疗[1]。高危因素为神经周围浸润、淋巴血管栓塞、淋巴结切除小于12、T4期、切除边缘阳性、梗阻和穿孔[2-4]。对于有高危因素的II期结肠癌患者,化疗是毫无疑问的。然而,化疗可能会产生副作用,使患者的依从性降低。医生们面临着这样的困境,尤其是那些年老或有严重合并症的病人。因此,本研究旨在根据高危因素的数量来确定II期结肠癌患者化疗的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The efficacy of chemotherapy in the patients with stage II colon cancer associated with number of high-risk factors
Treatment of colon cancer consists of surgical resection and chemotherapy. Stage II colon cancer is categorized into a high-risk group and low-risk group for recurrence, and chemotherapy is recommended for the high-risk group [1]. High-risk factors are perineural invasion, lymphovascular emboli, lymph node harvest less than 12, T4 stage, positive resection margin, obstruction, and perforation [2-4]. There is no doubt over treatment with chemotherapy for stage II colon cancer patients having high-risk factors. However, chemotherapy could cause side effects that makes patients’ compliance lower. Physicians face this dilemma, especially with patients who are old or have severe comorbidities. Therefore, this study was designed to determine the effectiveness of chemotherapy for patients with stage II colon cancer according to the number of high-risk factors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信